Clinical trial
Ursodeoxycholic Acid in Chronic Heart Failure
NCT00285597 · National Heart and Lung Institute, Other · Unknown status
Key facts
| NCT number | NCT00285597 |
|---|---|
| Title | Ursodeoxycholic Acid in Chronic Heart Failure |
| Official title | Ursodeoxycholic Acid Therapy in Chronic Heart Failure: A Placebo-controlled Study Evaluating the Effects of Ursodeoxycholic Acid on Peripheral Blood Flow and Immune Function |
| Lead sponsor | National Heart and Lung Institute, Other |
| Collaborators | Dr. Falk Pharma GmbH Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive |
| Intervention type | Drug |
| Interventions | Ursodeoxycholic Acid |
| Start date | May 1, 2004 |
| Completion | Jan 1, 2006 |
| First posted | Feb 2, 2006 |
| Last update posted | Oct 9, 2009 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: